Dr. Franz-Werner Haas, previously acting chief executive officer and chief operating officer, has been appointed as chief executive officer of CureVac.   Before Haas joined CureVac in June 2012, he worked as vice president operations and chief compliance officer of Sygnis Pharma AG, where he was responsible for the execution of M&A and capital market transactions. Haas started his professional career as an assistant to the management of a privately-held holding company before assuming severa...